|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4545 | (2006.01) |
| A61P 1/00 | (2006.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3275442 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16768810.0 |
| Europos patento paraiškos padavimo data | 2016-03-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-01-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-07-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2016/059162 |
| Data | 2016-03-23 |
| (87) | Numeris | WO 2016/152907 |
| Data | 2016-09-29 |
| (30) | Numeris | Data | Šalis |
| 201562138058 P | 2015-03-25 | US |
| (72) |
SHIBATA Tatsuhiro , JP
ARAI Yasuhito , JP
NOMOTO Kenichi , US
NAKAMURA Tomio , JP
TSURUOKA Akihiko , JP
MIYANO Saori , JP
|
| (73) |
National Cancer Center ,
5-1-1, Tsukiji
Chuo-ku, Tokyo 1040045,
JP
Eisai R&D Management Co., Ltd. , 4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088, JP |
| (54) | THERAPEUTIC AGENT FOR BILE DUCT CANCER |
| THERAPEUTIC AGENT FOR BILE DUCT CANCER |